{"SPADE_UN_11182": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 5831002 A", "Patent Link": "http://www.lens.org/lens/patent/US_5831002_A", "Patent Type": "Granted Patent", "Publication Date": "1998-11-3", "Family Info": "CA2219818A1,CA2219818C,CA2219819A1,CA2219819C,CN1182153C,CN1182154C,CN1187198A,CN1187199A,DE69623472D1,DE69623472T2,DE69623992D1,DE69623992", "Patent Title": "Antitumor peptides.", "Abstract": "Novel compounds of the formula EQU R.sup.1 R.sup.2 N--CHX-CO-A-B-D-(E).sub.s -(F).sub.t -(G).sub.U -KI in which R.sup.1, R.sup.2, A, B, D, E, F, G, K, X, s, t, and u have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect."}], "Sequence Information": {"SPADE ID": "SPADE_UN_11182", "Sequence": "XIXPX", "Sequence Length": 5, "Peptide Name": "Sequence 43 from Patent US 5831002", "Source": "Synthetic construct", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "XIP", "Absent Amino Acids": "ACDEFGHKLMNOQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00001", "Similarity": 1.0, "Sequence": "GSGVIPTISHECHMNSFQFVFTCCS"}, {"SPADE_ID": "SPADE_N_00009", "Similarity": 1.0, "Sequence": "SGIPCTIGAAVAASIAVCPTTKCSKRCGKRKK"}, {"SPADE_ID": "SPADE_N_00036", "Similarity": 1.0, "Sequence": "KKKSGVIPTVSHDCHMNTFQFMFTCCS"}]}}}